AI assistant
Sending…
ARVINAS, INC. — Director's Dealing 2020
Aug 18, 2020
32625_dirs_2020-08-18_9e7c2567-7de7-4b76-a10c-88fff0c5da39.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ARVINAS, INC. (ARVN)
CIK: 0001655759
Period of Report: 2020-08-14
Reporting Person: Peck Ronald (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-14 | Common Stock | M | 4010 | — | Acquired | 4010 | Direct |
| 2020-08-14 | Common Stock | S | 1256 | $27.46 | Disposed | 2754 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-08-14 | Restricted Stock Units | $ | M | 4010 | Disposed | Common Stock (4010) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
F2: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
F3: On July 29, 2019, the reporting person was granted 16,041 Restricted Stock Units, vesting in four equal annual installments beginning July 29, 2020.
More from ARVINAS, INC.
Regulatory Filings
2026
Jun 2
Earnings Release
2026
May 12
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 1
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Regulatory Filings
2026
Mar 18